• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, October 7, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Continued nicotine use promotes brain tumors in lung cancer patients, study suggests

Bioengineer by Bioengineer
June 4, 2020
in Chemistry
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Wake Forest researchers suggest nicotine replacement therapies may not be suitable smoking cessation strategies for this population

IMAGE

Credit: Wu et al., 2020

Researchers at Wake Forest School of Medicine have discovered that nicotine promotes the spread of lung cancer cells into the brain, where they can form deadly metastatic tumors. The study, which will be published June 4 in the Journal of Experimental Medicine (JEM), suggests that nicotine replacement therapies may not be suitable strategies for lung cancer patients attempting to quit smoking. In addition, the researchers show that the naturally occurring drug parthenolide blocks nicotine-induced brain metastasis in mice, suggesting a potential therapeutic option in humans.

Up to 40% of lung cancer patients develop brain metastasis, and the average survival time for these patients is less than six months. “There is an urgent need to understand the mechanisms that drive brain metastasis so that more effective therapies can be developed,” says Dr. Kounosuke Watabe, a professor of cancer biology at Wake Forest School of Medicine in Winston-Salem, NC.

Cigarette smoking is a major risk factor for lung cancer, but how it affects the development of brain metastasis is unclear. Watabe and colleagues studied 281 patients with advanced lung cancer and found that brain metastasis was much more common in patients who continued to smoke compared with patients who had never smoked or had successfully quit.

Watabe and colleagues found that, in mice, the spread of lung cancer cells to the brain is driven by nicotine, a major component of tobacco smoke that isn’t, in and of itself, carcinogenic. “Many cancer patients find it difficult to quit smoking even after their diagnosis due to nicotine addiction,” Watabe says. “E-cigarette, nicotine patch, and nicotine gum are commonly used as nicotine replacement therapies to help these patients cease smoking. However, our results clearly show that nicotine has profound and long-term effects on brain metastasis progression, suggesting that cancer patients should be cautious in their use of nicotine for smoking cessation.”

The tumors in patients’ brains contained large numbers of M2 microglia, a type of immune cell that secretes several molecules capable of enhancing tumor growth. The researchers found that nicotine stimulates the formation of M2 microglia in mice. Removing microglia from mouse brains prevented nicotine from inducing brain metastasis and enhanced the survival of mice with lung cancer.

Watabe and colleagues then looked for drugs that might reverse the effects of nicotine and identified parthenolide, a compound present at high levels in the medicinal herb Feverfew (Tanacetum parthenium), which has been used for centuries to treat headaches and inflammation. Treating mice with parthenolide prevented nicotine from stimulating the formation of M2 microglia and inhibited the spread of lung cancer cells to the brain, thereby improving the animals’ survival.

“We therefore think that parthenolide could be useful for the prevention and treatment of brain metastasis, particularly for patients with past and current smoking history,” Watabe says.

###

Wu et al., 2020. J. Exp. Med. https://rupress.org/jem/article-lookup/doi/10.1084/jem.20191131?PR

About the Journal of Experimental Medicine The Journal of Experimental Medicine (JEM) features peer-reviewed research on immunology, cancer biology, stem cell biology, microbial pathogenesis, vascular biology, and neurobiology. All editorial decisions are made by research-active scientists in conjunction with in-house scientific editors. JEM makes all of its content free online no later than six months after publication. Established in 1896, JEM is published by Rockefeller University Press. For more information, visit http://jem.org/>jem.org.

Visit our http://rupress.org/pages/newsroom>Newsroom, and sign up for a weekly preview of articles to be published. Embargoed media alerts are for journalists only.

Follow JEM on Twitter at https://twitter.com/jexpmed>@JExpMed and https://twitter.com/rockupress>@RockUPress.

Media Contact
Ben Short
[email protected]

Original Source

https://rupress.org/jem/article-lookup/doi/10.1084/jem.20191131?PR

Related Journal Article

http://dx.doi.org/10.1084/jem.20191131

Tags: cancerCarcinogensCell BiologyMedicine/HealthneurobiologyPharmaceutical SciencePublic HealthSmoking/Tobacco
Share12Tweet8Share2ShareShareShare2

Related Posts

Bright Red-NIR Glow from Carbodicarbene Borenium Ions

Bright Red-NIR Glow from Carbodicarbene Borenium Ions

October 6, 2025
blank

Transforming Biogas Waste into an Effective Solution for Ammonium Pollution Cleanup

October 6, 2025

Scientists Incorporate Waveguide Physics into Metasurfaces to Unlock Advanced Light Manipulation

October 6, 2025

Scientists Develop “Knob” to Control Topological Spin Textures in Materials

October 6, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    95 shares
    Share 38 Tweet 24
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    93 shares
    Share 37 Tweet 23
  • Ohio State Study Reveals Protein Quality Control Breakdown as Key Factor in Cancer Immunotherapy Failure

    74 shares
    Share 30 Tweet 19
  • New Insights Suggest ALS May Be an Autoimmune Disease

    72 shares
    Share 29 Tweet 18

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

New Insights into Endothelial Cell Death in Sepsis

LVSG Effects on LES and GERD: Meta-Analysis

PRDM6: A Key Protector Against PCOS

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.